Inventor
HENDERSON SAMUEL T
US12 patents
⚠️ This page may combine multiple inventors who share the name “HENDERSON SAMUEL T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HENDERSON SAMUEL T
7 patentsUS8748400B2Jun 10, 2014
Use of ketogenic compounds for treatment of age-associated memory impairment
HENDERSON SAMUEL T48 citations96
US8426468B2Apr 23, 2013
Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease and other diseases resulting from reduced neuronal metabolism
HENDERSON SAMUEL T56 citations96
US8124589B2Feb 28, 2012
Use of ketogenic compounds for treatment of age-associated memory impairment
HENDERSON SAMUEL T68 citations96
US8445535B1May 21, 2013
Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
HENDERSON SAMUEL T9 citations82
US9125881B2Sep 8, 2015
Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders
HENDERSON SAMUEL T4 citations71
US9175345B2Nov 3, 2015
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
HENDERSON SAMUEL T0 citations50
US8105809B2Jan 31, 2012
Enzymatic synthesis of acetoacetate esters and derivatives
HENDERSON SAMUEL T0 citations50
ACCERA INC
4 patentsUS6835750B1Dec 28, 2004
Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ACCERA INC178 citations96
US10111849B2Oct 30, 2018
Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ACCERA INC7 citations82
US9603823B2Mar 28, 2017
Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ACCERA INC2 citations71
US10105338B2Oct 23, 2018
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
ACCERA INC0 citations50